申请人:Warner-Lambert Company
公开号:US05658943A1
公开(公告)日:1997-08-19
Novel antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, essential, renovascular, malignant and pulmonary hypertension, cerebral infarction, myocardial ischemia, cerebral ischemia, congestire heart failure and subarachnoid hemorrhage.
本发明涉及内皮素的新拮抗剂,以及用于其制备的新中间体,以及制备方法和药物组合物,可用于治疗内皮素水平升高、本质性、肾血管性、恶性和肺动脉高压、脑梗塞、心肌缺血、脑缺血、充血性心力衰竭和蛛网膜下腔出血。